Patient-centricity needs to be more than a buzzword. Here’s how Boehringer Ingelheim is weaving it into its culture.

High growth predictions for regenerative medicine are exciting, but what if current capacity can’t keep pace?

Discussing the challenges associated with flu vaccine development – and the emerging technologies hoping to tackle them.

Carl June discusses his pathway into immunology, and the history and success of CAR-T therapy.

From StomachSim, to taste masking, to micronization; check out our special eBook on Formulation

Researchers use genome mining and bioengineering techniques to develop sustainable saponin-based vaccine adjuvants

Modern data strategies are needed as the landscape for clinical trials changes.

The wait is over. Our annual celebration of the pharma industry’s most influential individuals has returned!

It’s been 200 years since the death of Edward Jenner – but how best to celebrate his achievement?

How are the last few years of pharmaceutical industry trends affecting the drug delivery landscape – and what opportunities should we grasp?